Table 1.
Midazolam/hydromorphone (n = 92) | Midazolam/meperidine (n = 65) | P valuea | |
---|---|---|---|
Age, mean (SD), y | 4.02 (0.8) | 4.03 (0.7) | .94 |
Gender, n (%) | .62 | ||
Male | 39 (42.4) | 31 (47.7) | |
Female | 53 (57.6) | 34 (52.3) | |
Weight, mean (SD), kg | 17.1 (1.7) | 17.0 (1.8) | .72 |
Midazolam dosing | |||
Total dose, mean (SD), mg | 16.7 (2.1) | 15.5 (2.6) | .002b |
Weight-based dose, mean (SD), mg/kg | 0.98 (0.07) | 0.91 (0.11) | <.001b |
Hydromorphone dosing | |||
Total dose, mean (SD), mg | 0.5 (0.1) | — | n/a |
Weight-based dose, mean (SD), mg/kg | 0.03 (0.004) | — | n/a |
Meperidine dosing | |||
Total dose, mean (SD), mg | — | 23.8 (6.2) | n/a |
Weight-based dose, mean (SD), mg/kg | — | 1.4 (0.3) | n/a |
Chi-square or Fisher exact test, unless otherwise indicated.
P < .05.